Hypoplastic Left Heart Syndrome
Last Posted: Dec 21, 2020
- Genetic Association between Hypoplastic Left Heart Syndrome and Cardiomyopathies.
Theis Jeanne L et al. Circulation. Genomic and precision medicine 2020 Dec
- Improving preoperative risk-of-death prediction in surgery congenital heart defects using artificial intelligence model: A pilot study.
Chang Junior João et al. PloS one 2020 15(9) e0238199
- Contribution of single-gene defects to congenital cardiac left-sided lesions in the prenatal setting.
Sun Hairui, et al. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019 10
- Loss of function, missense, and intronic variants in NOTCH1 confer different risks for left ventricular outflow tract obstructive heart defects in two European cohorts.
Helle Emmi, et al. Genetic epidemiology 2019 0 (2) 215-226
- Impact of MYH6 variants in hypoplastic left heart syndrome.
Tomita-Mitchell Aoy, et al. Physiological genomics 2016 0 (12) 912-921
- Copy Number Variants of Undetermined Significance Are Not Associated with Worse Clinical Outcomes in Hypoplastic Left Heart Syndrome.
Dailey-Schwartz Andrew L et al. The Journal of pediatrics 2018 Aug
- Familial Screening for Left-Sided Congenital Heart Disease: What Is the Evidence? What Is the Cost?
Perry Daniel J et al. Diseases (Basel, Switzerland) 2017 Dec 5(4)
- Adrenergic receptor genotypes influence postoperative outcomes in infants in the Single-Ventricle Reconstruction Trial.
Ramroop Ronand, et al. The Journal of thoracic and cardiovascular surgery 2017 6
- Tetralogy of Fallot and Hypoplastic Left Heart Syndrome - Complex Clinical Phenotypes Meet Complex Genetic Networks.
Lahm Harald et al. Curr. Genomics 2015 Jun (3) 141-58
- Variants in the NOTCH1 gene in patients with aortic coarctation.
Freylikhman Olga, et al. Congenital heart disease 0 0 (5) 391-6
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.